Heparin Anticoagulant Therapy and Its Monitoring
Biomolecules · 13.03.2026 · 16 (3) · 425
DOI: 10.3390/biom16030425 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 13.03.2026. Verfasst von Benjamin Reardon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Joint Medical Program, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW 2145, Australia. Hauptthemen laut MEDLINE: Anticoagulants, Heparin, Drug Monitoring. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Heparin remains a foundational parenteral anticoagulant across both acute and chronic care settings. This narrative review summarizes clinical indications and dosing of unfractionated (UFH) and low-molecular-weight heparin (LMWH). It also details laboratory monitoring using activated partial thromboplastin (APTT), anti-factor Xa (anti-Xa), activated clotting time (ACT) and viscoelastic testing (VET), including common pitfalls and interferences. We provide considerations for specific populations as well as complications including heparin resistance, heparin-induced thrombocytopenia (HIT) and heparin reversal strategies. Future research directions include harmonization of therapeutic ranges, mitigation of assay interference and prospective evaluation on monitoring, particular in extracorporeal membrane oxygenation (ECMO), pregnancy and cardiac surgical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint Medical Program, School of Medicine and Public Health, University of Newcastle, Callaghan, NSW 2145, Australia.
- Haematology Department, Calvary Mater Hospital Newcastle, Waratah, NSW 2298, Australia.
- Haematology Department, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, NSW 2145, Australia.
- Westmead Clinical School, University of Sydney, Westmead, NSW 2145, Australia.
- Sydney Centres for Thrombosis and Haemostasis, Research and Education Network (REN) and Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, NSW 2145, Australia.
- Section of Clinical Biochemistry, University of Verona, 37129 Verona, Italy.
ORCID-Profile: Benjamin Reardon, Leonardo Pasalic, Giuseppe Lippi, Emmanuel J Favaloro
Zitieren
APA
Reardon, B., Pasalic, L., Lippi, G., & Favaloro, E. J. (2026). Heparin Anticoagulant Therapy and Its Monitoring. Biomolecules, 16(3), 425. https://doi.org/10.3390/biom16030425
Vancouver
Reardon B, Pasalic L, Lippi G, Favaloro EJ. Heparin Anticoagulant Therapy and Its Monitoring. Biomolecules. 2026;16(3):425. doi:10.3390/biom16030425
BibTeX
@article{Reardon2026,
author = {Reardon, Benjamin and Pasalic, Leonardo and Lippi, Giuseppe and Favaloro, Emmanuel J},
title = {Heparin Anticoagulant Therapy and Its Monitoring},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {3},
pages = {425},
doi = {10.3390/biom16030425}
}
EUVIMED